Connect with us

Business

Novavax delays Covid vaccine emergency authorization submission to FDA until fourth quarter – CNBC

Article feature image
ADVERTISEMENT

Novavax announced that it will delay the submission of its Covid-19 vaccine to the Food and Drug Administration for emergency use authorization until its fourth quarter.
Shares of the biotechnology company slipped 10% after the bell.
The company has filed…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
NTSB says Tesla’s Full Self-Driving beta is ‘misleading & irresponsible’ ahead of wider release – Electrek
Article feature image
NTSB says Tesla’s Full Self-Driving beta is ‘misleading & irresponsible’ ahead of wider release – Electrek